COVID-19 Clinical Trials at Sarasota Memorial
Since the beginning of the COVID-19 pandemic, Sarasota Memorial has proudly been among selected U.S. hospitals participating in national and multi-national clinical research trials focused on preventing and treating COVID-19.
For eligibility questions related to current COVID-19 Clinical Trials at Sarasota Memorial, call the SMH Clinical Research Center at 941-917-2225 (8am-3pm, Monday-Friday).
COVID-19 Anti-CD14 Treatment Trial (CaTT) for Inpatients
Sarasota Memorial Hospital is among the research sites across the U.S. participating in a multi-center trial of IC14, an anti-CD14 monoclonal antibody drug that researchers hope will reduce dangerous levels of inflammation in COVID-19 patients. To be eligible for the COVID-19 anti-CD14 Treatment Trial (CaTT), study participants must be hospitalized with COVID-19, require oxygen support and meet other clinical criteria.
For more information, click here or call Sarasota Memorial’s Clinical Research Center at 941-917-2225 (8 am to 3 pm, Monday to Friday).
** This webpage was last updated Dec. 29, 2021.